Some investigators have reported a survival benefit for patients with a high TS expression treated with 5-FU in adjuvant and metastatic colorectal cancer (Johnston et al, 1995; Edler et al, 2002; Soong and Diasio, 2005). Here, TYMS is linked to metastatic colorectal cancer.